홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
QURE
#2145
uniQure N.V.
15.6
3
-9.76%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-9.76%
월간 변동
-34.90%
6달 변화
-1.01%
년간 변동율
+33.02%
이전 종가
17.3
2
Open
15.6
3
Bid
Ask
Low
15.6
3
High
15.6
3
양
137
마켓
주식
헬스케어
QURE
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
uniQure N.V
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
뉴스
uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know (NASDAQ:QURE)
uniQure-Quartalszahlen: Zulassungsweg für Hoffnungsträger AMT-130 im Fokus
uniQure earnings in focus as AMT-130 regulatory path looms
Stifel bewertet uniQure nach Äußerungen des FDA-Commissioners zu seltenen Krankheiten
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Applied Materials, Broadcom among market cap stock movers on Thursday
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
UniQure-Aktie bricht nach FDA-Kommentaren zu Gentherapie-Studie ein
UniQure stock tumbles on FDA comments about gene therapy trial
uniQure: Wolfe Research nimmt Bewertung mit „Peerperform“ auf
uniQure stock initiated at Peerperform by Wolfe Research